Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation

The Jackknife, the Bootstrap and Other Resampling Plans

Efron, B. (1982) · Society for Industrial and Applied Mathematics eBooks · doi:10.1137/1.9781611970319 · Cited by 8,120 · see citing works

Antibody responses to SARS-CoV-2 in patients with COVID-19

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876 · see citing works

The Jackknife: The Bootstrap and Other Resampling Plans.

Low, L. Y., & Efron, B. (1983) · Journal of the American Statistical Association · doi:10.2307/2288218 · Cited by 2,728 · see citing works

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686 · see citing works

SARS-CoV-2 Infection in Children

Lü, X., Zhang, L., Du, H. N., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,423 · see citing works

A wilcoxon‐type test for trend

Cuzick, J. M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040112 · Cited by 1,920 · see citing works

A serological assay to detect SARS-CoV-2 seroconversion in humans

Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769 · see citing works

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M. A., Pérez-Olmeda, M., Sanmartín, J. L., Fernández-García, A., Cruz, I., Fernández de Larrea, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31483-5 · Cited by 1,639 · see citing works

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310 · see citing works

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195 · see citing works

CBMS-NSF REGIONAL CONFERENCE SERIES IN APPLIED MATHEMATICS

Gottlieb, D., Orszag, S. A., Huber, P. J., & Roberts, F. S. (2011) · Cited by 999 · see citing works

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Premkumar, L., Segovia-Chumbez, B., Jadi, R., Martinez, D. R., Raut, R., Markmann, A. J., Cornaby, C., Bartelt, L., Weiss, S., Park, Y., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc8413 · Cited by 868 · see citing works

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

Bastos, M. L., Tavaziva, G., Abidi, S. K., Campbell, J. R., Haraoui, L., Johnston, J. C., Lan, Z., Law, S. J., MacLean, E. L.-H., Trajman, A., et al. (2020) · BMJ · doi:10.1136/bmj.m2516 · Cited by 832 · see citing works

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746 · see citing works

Uses and abuses of screening tests

Grimes, D. A., & Schulz, K. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07948-5 · Cited by 545 · see citing works

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Klein, S. L., Pekosz, A. S., Park, H.-S., Ursin, R. L., Shapiro, J. R., Benner, S. E., Littlefield, K. E., Kumar, S., Naik, H. M., Betenbaugh, M. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142004 · Cited by 424 · see citing works

The Role of Antibody Testing for SARS-CoV-2: Is There One?

Theel, E. S., Slev, P. R., Wheeler, S., Couturier, M. R., Wong, S. J., & Kadkhoda, K. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00797-20 · Cited by 303 · see citing works

Analyzing small data sets using Bayesian estimation: the case of posttraumatic stress symptoms following mechanical ventilation in burn survivors

van de Schoot, R., Broere, J., Perryck, K. H., Zondervan-Zwijnenburg, M. A. J., & Loey, N. E. E. V. (2015) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v6.25216 · Cited by 276 · see citing works

Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies

Montesinos, I., Gruson, D., Kabamba, B., Dahma, H., den Wijngaert, S. V., Soleimani, R., Carbone, V., Vandenberg, O., Gulbis, B., Wolff, F., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104413 · Cited by 271 · see citing works

How the pandemic might play out in 2021 and beyond

Scudellari, M. (2020) · Nature · doi:10.1038/d41586-020-02278-5 · Cited by 246 · see citing works

Magnitude and Kinetics of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity

Lynch, K. L., Whitman, J. D., Lacanienta, N. P., Beckerdite, E. W., Kastner, S. A., Shy, B. R., Goldgof, G. M., Levine, A. G., Bapat, S. P., Stramer, S. L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa979 · Cited by 211 · see citing works

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays

Kohmer, N., Westhaus, S., Rühl, C., Ciesek, S., & Rabenau, H. F. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104480 · Cited by 187 · see citing works

Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses

Lustig, Y., Keler, S., Kolodny, R., Ben‐Tal, N., Atias-Varon, D., Shlush, E., Gerlic, M., Munitz, A., Doolman, R., Asraf, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1207 · Cited by 171 · see citing works

Primary vaccine failure to routine vaccines: Why and what to do?

Wiedermann, U., Garner‐Spitzer, E., & Wagner, A. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1093263 · Cited by 156 · see citing works

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity

McAndrews, K. M., Dowlatshahi, D. P., Dai, J., Becker, L. M., Hensel, J., Snowden, L. M., Leveille, J. M., Brunner, M. R., Holden, K. W., Hopkins, N. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142386 · Cited by 126 · see citing works

A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients

Chen, Y., Tong, X., Li, Y., Gu, B., Yan, J., Liu, Y., Shen, H., Huang, R., & Wu, C. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008796 · Cited by 103 · see citing works

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1

Friedman, N., Alter, H., Hindiyeh, M. Y., Mendelson, E., Avni, Y. S., & Mandelboim, M. (2018) · Viruses · doi:10.3390/v10100515 · Cited by 102 · see citing works

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies

Charlton, C. L., Kanji, J. N., Johal, K., Bailey, A., Plitt, S. S., MacDonald, C., Kunst, A., Buss, E., Burnes, L. E., Fonseca, K., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01361-20 · Cited by 96 · see citing works

Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers

Bruni, M., Cecatiello, V., Díaz‐Basabe, A., Lattanzi, G., Mileti, E., Monzani, S., Pirovano, L., Rizzelli, F., Visintin, C., Bonizzi, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103188 · Cited by 75 · see citing works

Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS

Fierz, W., & Walz, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01120 · Cited by 64 · see citing works

Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020

Bogogiannidou, Z., Vontas, A., Dadouli, K., Kyritsi, M. A., Soteriades, S., Nikoulis, D. J., Mouchtouri, V. Α., Koureas, M., Kazakos, E. I., Spanos, E., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.31.2001369 · Cited by 60 · see citing works

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Levin, E. G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114583 · Cited by 1,703 · see citing works

BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers

Lustig, Y., Sapir, E., Regev-Yochay, G., Cohen, C., Fluss, R., Olmer, L., Indenbaum, V., Mandelboim, M., Doolman, R., Amit, S., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00220-4 · Cited by 342 · see citing works

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

(2021) · doi:10.1016/j.eclinm.2021.100861 · Cited by 201 · see citing works

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

Lau, J. J., Cheng, S. M. S., Leung, K., Lee, C. K., Hachim, A., Tsang, L. C. H., Yam, K. W. H., Chaothai, S., Kwan, K. K. H., Chai, Z. Y. H., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02219-5 · Cited by 198 · see citing works

The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children

Dattner, I., Goldberg, Y., Katriel, G., Yaari, R., Gal, N., Miron, Y., Ziv, A., Sheffer, R., Hamo, Y., & Huppert, A. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008559 · Cited by 182 · see citing works

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays

Perkmann, T., Perkmann‐Nagele, N., Köller, T., Mucher, P., Radakovics, A., Marculescu, R., Wolzt, M., Wagner, O. F., Binder, C. J., & Haslacher, H. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00247-21 · Cited by 181 · see citing works

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in People Living with HIV-1

Levy, I., Wieder-Finesod, A., Litchevski, V., Biber, A., Indenbaum, V., Olmer, L., Huppert, A., Mor, O., Goldstein, M., Levin, E. G., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.07.031 · Cited by 171 · see citing works

Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar

Abu-Raddad, L. J., Chemaitelly, H. S., Ayoub, H. H., Yassine, H. M., Benslimane, F. M., Al-Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P. V., Kanaani, Z. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.19623 · Cited by 165 · see citing works

BNT162b2 COVID ‐19 vaccine is significantly less effective in patients with hematologic malignancies

Tzarfati, K. H., Gutwein, O., Apel, A., Rahimi‐Levene, N., Sadovnik, M., Harel, L., Benveniste‐Levkovitz, P., Chaim, A. B., & Koren‐Michowitz, M. (2021) · American Journal of Hematology · doi:10.1002/ajh.26284 · Cited by 157 · see citing works

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Perry, C., Luttwak, E., Balaban, R., Shefer, G., Morales, M., Aharon, A., Tabib, Y., Cohen, Y. C., Benyamini, N., Beyar‐Katz, O., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005094 · Cited by 153 · see citing works

How to interpret and use COVID-19 serology and immunology tests

Ong, D. S. Y., Fragkou, P. C., Schweitzer, V. A., Chemaly, R. F., Moschopoulos, C. D., & Skevaki, C. L. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.05.001 · Cited by 140 · see citing works

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Wei, J., Matthews, P. C., Stoesser, N. E., Maddox, T., Lorenzi, L., Studley, R., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26479-2 · Cited by 131 · see citing works

Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

Follmann, D. A., Janes, H., Buhule, O. D., Zhou, H., Girard, B., Marks, K., Kotloff, K. L., Desjardins, M., Corey, L., Neuzil, K. M., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m22-1300 · Cited by 126 · see citing works

Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy

Nir, O., Schwartz, A., Toussia‐Cohen, S., Leibovitch, L., Strauss, T., Asraf, K., Doolman, R., Sharabi, S., Cohen, C., Lustig, Y., et al. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100492 · Cited by 115 · see citing works

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

Regev-Yochay, G., Amit, S., Bergwerk, M., Lipsitch, M., Leshem, E., Kahn, R., Lustig, Y., Cohen, C., Doolman, R., Ziv, A., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100150 · Cited by 111 · see citing works

Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay

Riester, E., Findeisen, P., Hegel, J. K., Kabesch, M., Ambrosch, A., Rank, C. M., Pessl, F., Laengin, T., & Niederhauser, C. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114271 · Cited by 107 · see citing works

Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience

Peled, Y., Ram, E., Ii Jacob Lavee, I., Segev, A., Matezky, S., Wieder-Finesod, A., Halperin, R., Mandelboim, M., Indenbaum, V., Levy, I., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.08.010 · Cited by 99 · see citing works

Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar

Jeremijenko, A., Chemaitelly, H., Ayoub, H. H., Alishaq, M., Abou-Samra, A.-B., Al Ajmi, J. A. A. A., Al Ansari, N. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., et al. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2705.204365 · Cited by 97 · see citing works

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Benjamini, O., Rokach, L., Itchaki, G., Braester, A., Shvidel, L., Goldschmidt, N., Shapira, S., Dally, N., Avigdor, A., Rahav, G., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279196 · Cited by 97 · see citing works

Comparison of Seroconversion in Children and Adults With Mild COVID-19

Toh, Z. Q., Anderson, J., Mazarakis, N., Neeland, M. R., Higgins, R. A., Rautenbacher, K., Dohle, K., Nguyen, J., Overmars, I., Donato, C. M., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.1313 · Cited by 96 · see citing works

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

Coyle, P. V., Chemaitelly, H., Ben Hadj Kacem, M. A., Abdulla Al Molawi, N. H., El Kahlout, R. A., Gilliani, I., Younes, N., Al Anssari, G. A. A. A., Al Kanaani, Z., Al Khal, A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102646 · Cited by 86 · see citing works

Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections

Abu-Raddad, L. J., Chemaitelly, H. S., Ayoub, H. H., Tang, P., Coyle, P. V., Hasan, M. R., Yassine, H. M., Benslimane, F. M., Al-Khatib, H. A., Kanaani, Z. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28199-7 · Cited by 79 · see citing works

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201

Wiens, K. E., Mawien, P. N., Rumunu, J. P., Slater, D., Jones, F. K., Moheed, S., Caflisch, A. C., Bior, B. K., Jacob, I. A., Lako, R. L. L., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2706.210568 · Cited by 74 · see citing works

BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study

Rahav, G., Lustig, Y., Ii Jacob Lavee, I., Benjamini, O., Magen, H., Hod, T., Shem‐Tov, N., Shmueli, E., Merkel, D. G., Ben‐Ari, Z., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101158 · Cited by 74 · see citing works

Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study

Bartsch, S. M., O'Shea, K. J., Chin, K. L., Strych, U., Ferguson, M. C., Bottazzi, M. E., Wedlock, P. T., Cox, S. N., Siegmund, S. S., Hotez, P. J., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(22)00040-8 · Cited by 70 · see citing works

Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients

Shem‐Tov, N., Yerushalmi, R., Danylesko, I., Litachevsky, V., Levy, I., Olmer, L., Lusitg, Y., Avigdor, A., Nagler, A., Shimoni, A., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17918 · Cited by 65 · see citing works

Predictors of Nonseroconversion after SARS-CoV-2 Infection

Liu, W., Russell, R. M., Bibollet‐Ruche, F., Skelly, A. N., Sherrill-Mix, S. A., Freeman, D. A., Stoltz, R., Lindemuth, E., Lee, F.-H., Sterrett, S., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2709.211042 · Cited by 58 · see citing works

Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020

Hövener, C., Neuhauser, H. K., Rosario, A. S., Busch, M. A., Schlaud, M., Hoffmann, R. G., Gößwald, A., Koschollek, C., Hoebel, J., Allen, J., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.47.2001752 · Cited by 55 · see citing works

SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection

Zhan, Y., Zhu, Y., Wang, S., Jia, S., Gao, Y., Lü, Y., Zhou, C.-L., Liang, R., Sun, D., Wang, X., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00777-z · Cited by 51 · see citing works

COVID ‐19 and plasma cells: Is there long‐lived protection?*

Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 44 · see citing works

Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies

Hod, T., Ben‐David, A., Olmer, L., Levy, I., Ghinea, R., Mor, E., Lustig, Y., & Rahav, G. (2021) · Transplantation · doi:10.1097/tp.0000000000003889 · Cited by 43 · see citing works

A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients

Davidov, Y., Indenbaum, V., Tsaraf, K., Cohen‐Ezra, O., Likhter, M., Yakov, G. B., Halperin, R., Levy, I., Mor, O., Agmon‐Levin, N., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.042 · Cited by 43 · see citing works

Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study

Shmueli, E., Itay, A., Margalit, O., Berger, R., Halperin, S., Jurkowicz, M., Levin, E. G., Levy, I., Olmer, L., Regev‐Yochay, G., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.007 · Cited by 42 · see citing works

Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure

Demonbreun, A. R., McDade, T. W., Pesce, L. L., Vaught, L. A., Reiser, N. L., Bogdanovic, E., Velez, M. P., Hsieh, R. R., Simons, L. M., Saber, R., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146148 · Cited by 40 · see citing works

Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients

Davidov, Y., Tsaraf, K., Cohen‐Ezra, O., Likhter, M., Yakov, G. B., Levy, I., Levin, E. G., Lustig, Y., Mor, O., Rahav, G., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26366 · Cited by 37 · see citing works

Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits

Al-Jighefee, H. T., Yassine, H. M., Al‐Nesf, M. A., Hssain, A. A., Taleb, S., Mohamed, A. S., Maatoug, H., Mohamedali, M. G. H., & Nasrallah, G. K. (2021) · Pathogens · doi:10.3390/pathogens10020161 · Cited by 36 · see citing works

Endemic does not mean constant as SARS-CoV-2 continues to evolve

Otto, S. P., MacPherson, A., & Colijn, C. (2024) · Evolution · doi:10.1093/evolut/qpae041 · Cited by 31 · see citing works

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel

Reicher, S., Ratzon, R., Ben-Sahar, S., Alon, S. H., Mossinson, D., Shenhar, Y., Friger, M. D., Lustig, Y., Alroy‐Preis, S., Anis, E., et al. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00749-1 · Cited by 31 · see citing works

Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG

Winklmeier, S., Eisenhut, K., Taskin, D., Rübsamen, H., Gerhards, R., Schneider, C., Wratil, P. R., Stern, M., Eichhorn, P., Keppler, O. T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103659 · Cited by 30 · see citing works

Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay

Irsara, C., Egger, A., Prokop, W., Nairz, M., Loacker, L., Sahanic, S., Pizzini, A., Sonnweber, T., Mayer, W., Schennach, H., et al. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1758 · Cited by 29 · see citing works

Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts

Dobaño, C., Alonso, S., Vidal, M., Jiménez, A., Rubio, R., Santano, R., Barrios, D., Pons-Tomàs, G., Melé-Casas, M., Hernández, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.751705 · Cited by 28 · see citing works

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG

Eberhardt, K. A., Dewald, F., Heger, E., Gieselmann, L., Vanshylla, K., Wirtz, M., Kleipass, F., Johannis, W., Schommers, P., Gruell, H., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040733 · Cited by 25 · see citing works

Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in older residents of a long-term care facility: relation with age, frailty and prior infection status

Seiffert, P., Konka, A., Kasperczyk, J., Kawa, J., Lejawa, M., Maślanka-Seiffert, B., Zembala-John, J., Bugdol, M. N., Romanik, M. K., Bułdak, R. J., et al. (2021) · Biogerontology · doi:10.1007/s10522-021-09944-9 · Cited by 24 · see citing works

SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore

Lau, C. S., Phua, S. K., Liang, Y. L., Oh, M. L. H., & Aw, T. C. (2022) · Vaccines · doi:10.3390/vaccines10020331 · Cited by 24 · see citing works

BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients

Hod, T., Ben‐David, A., Olmer, L., Scott, N., Ghinea, R., Mor, E., Levy, I., Indenbaum, V., Lustig, Y., Grossman, E., et al. (2022) · Transplant International · doi:10.3389/ti.2022.10239 · Cited by 22 · see citing works

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia

Sekirov, I., Barakauskas, V., Simons, J. E., Cook, D. A., Bates, B., Burns, L., Masud, S., Charles, M., McLennan, M., Mak, A., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104914 · Cited by 22 · see citing works

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

Tadmor, T., Benjamini, O., Braester, A., Rahav, G., & Rokach, L. (2021) · Leukemia · doi:10.1038/s41375-021-01380-5 · Cited by 21 · see citing works

Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic

Boehme, K. W., Kennedy, J. L., Snowden, J. N., Owens, S. M., Kouassi, M., Mann, R., Paredes, A., Putt, C., James, L. P., Jin, J., et al. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac010 · Cited by 20 · see citing works

Serological testing for SARS‐CoV‐2 antibodies in clinical practice: A comparative diagnostic accuracy study

Horn, M. P., Jónsdóttir, H. R., Brigger, D., Damonti, L., Suter‐Riniker, F., Endrich, O., Froehlich, T. K., Fiedler, M., Largiadèr, C. R., Marschall, J., et al. (2022) · Allergy · doi:10.1111/all.15206 · Cited by 20 · see citing works

Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods

Emmerich, P., von Possel, R., Hemmer, C. J., Fritzsche, C., Geerdes-Fenge, H. F., Menge, B., Messing, C., Borchardt‐Lohölter, V., Deschermeier, C., & Steinhagen, K. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27113 · Cited by 19 · see citing works

Evaluation of spike protein antigens for SARS-CoV-2 serology

Jagtap, S., Ratnasri, K., Valloly, P., Sharma, R., Maurya, S., Gaigore, A., Ardhya, C., Biligi, D. S., Desiraju, B. K., Natchu, U. C. M., et al. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114222 · Cited by 18 · see citing works

The Role and Diagnostic Accuracy of Serology for COVID-19

Kundu, D., Gautam, P., Dayanand, D., Gunasekaran, K., Abi Manesh, S., Sebastian, M., Abhilash, K. P. P., Zachariah, A., George, T., Sathyendra, S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-022-07361-y · Cited by 18 · see citing works

Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain

Pérez‐Olmeda, M., Saugar, J. M., Fernández-García, A., Pérez‐Gómez, B., Pollán, M., Avellón, A., Pastor‐Barriuso, R., de Larrea, N. F., Martín, M., Cruz, I., et al. (2022) · Journal of Clinical Virology · doi:10.1016/j.jcv.2022.105130 · Cited by 17 · see citing works

Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2

Riester, E., Majchrzak, M., Mühlbacher, A., Tinguely, C., Findeisen, P., Hegel, J. K., Laimighofer, M., Rank, C. M., Schönfeld, K., Langen, F., et al. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00504-9 · Cited by 17 · see citing works

Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassayPreprint

Riester, E., Findeisen, P., Hegel, J. K., Kabesch, M., Ambrosch, A., Rank, C. M., Langen, F., Laengin, T., & Niederhauser, C. (2021) · medRxiv · doi:10.1101/2021.03.02.21252203 · Cited by 17 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern

Lyski, Z. L., Brunton, A. E., Strnad, M., Sullivan, P. E., Siegel, S. A. R., Tafesse, F., Slifka, M. K., & Messer, W. B. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab585 · Cited by 15 · see citing works

Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021

Indenbaum, V., Lustig, Y., Mendelson, E., Hershkovitz, Y., Glatman‐Freedman, A., Keinan‐Boker, L., & Bassal, R. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.48.2101040 · Cited by 14 · see citing works

Longitudinal Profile of Antibody Response to SARS-CoV-2 in Patients with COVID-19 in a Setting from Sub–Saharan Africa: A Prospective Longitudinal Study

Gebrecherkos, T., Kiros, Y. K., Challa, F., Abdella, S., Gebreegzabher, A., Leta, D., Desta, A. A., Atsbaha, A. H., Tasew, G., Abdulkader, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0263627 · Cited by 14 · see citing works

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients

Hamaya, T., Hatakeyama, S., Yoneyama, T., Tobisawa, Y., Kodama, H., Fujita, T., Murakami, R., Fujita, N., Okamoto, T., Yamamoto, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09897-0 · Cited by 13 · see citing works

Adaptation‐Proof SARS‐CoV‐2 Vaccine Design

Vishweshwaraiah, Y. L., Hnath, B., Rackley, B., Wang, J., Gontu, A., Chandler, M. R., Afonin, K. A., Kuchipudi, S. V., Christensen, N. D., Yennawar, N. H., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202206055 · Cited by 12 · see citing works

Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama

Guardia, C. D. L., Rangel, G. A., Villarreal, A. E., Goodridge, A., Fernández, P. L., & Lleonart, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257351 · Cited by 12 · see citing works

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study

Zhou, K., Blanc-Lapierre, A., Seegers, V., Boisdron‐Celle, M., Bigot, F., Bourdon, M., Mahammedi, H., Lambert, A., Campone, M., Conroy, T., et al. (2021) · Cancers · doi:10.3390/cancers13143389 · Cited by 11 · see citing works

Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients

Guzmán-Martínez, O., Guardado, K., Cardoso, M. V., Trujillo-Rivera, A., Marı́n-Hernández, A., León, M. C. O., Gómez-Ñañez, I., Gutiérrez, M., Espinosa, R., Sampieri, C. L., et al. (2021) · Infection · doi:10.1007/s15010-021-01705-7 · Cited by 11 · see citing works

Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay

Alshami, A., Attas, R. A. A., Anan, H., Maghrabi, A. A., Ghandorah, S. S., Mohammed, A., Alhalimi, A. A., Al-Jishi, J. M., & Alqahtani, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.770727 · Cited by 11 · see citing works

Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19

Chamkhi, S., Dhaouadi, T., Sfar, I., Mokni, S., Jebri, A., Mansouri, D., Ghedira, S., Jemia, E. B., Boujemaa, S. B., Houissa, M., et al. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211073232 · Cited by 11 · see citing works

The role of statisticians in the response to COVID-19 in Israel: a holistic point of view

Dattner, I., Gal, R., Goldberg, Y., Goldshtein, I., Huppert, A., Kenett, R. S., Manor, O., Pfeffermann, D., Schechtman, E., Serio, C. D., et al. (2022) · Israel Journal of Health Policy Research · doi:10.1186/s13584-022-00531-y · Cited by 11 · see citing works

Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology

Perkmann, T., Köller, T., Perkmann‐Nagele, N., Ozsvár-Kozma, M., Eyre, D. W., Matthews, P. C., Bown, A., Stoesser, N. E., Breyer, M., Breyer‐Kohansal, R., et al. (2022) · Journal of Clinical Pathology · doi:10.1136/jcp-2022-208171 · Cited by 10 · see citing works

Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders

Montague, B. T., Wipperman, M. F., Hooper, A. T., Hamon, S., Crow, R., Elemo, F., Hersh, L., Langdon, S., Hamilton, J. D., O’Brien, M. P., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab524 · Cited by 10 · see citing works

SARS-CoV-2 BNT162b2 vaccine–induced humoral response and reactogenicity in individuals with prior COVID-19 disease

Kelsen, S. G., Braverman, A. S., Aksoy, M. O., Hayman, J. A., Patel, P. S., Rajput, C., Zhao, H., Fisher, S. G., Ruggieri, M. R., & Gentile, N. (2022) · JCI Insight · doi:10.1172/jci.insight.155889 · Cited by 10 · see citing works

Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis

Aubry, A., Demey, B., François, C., Duverlie, G., Castelain, S., Helle, F., & Brochot, É. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091815 · Cited by 10 · see citing works

Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings

Andrey, D. O., Yerly, S., Meyer, B., Arm‐Vernez, I., Roux‐Lombard, P., Togni, G., Guessous, I., Spechbach, H., Stringhini, S., Agoritsas, T., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081605 · Cited by 9 · see citing works

SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020

Craigie, A., McGregor, R., Whitcombe, A. L., Carlton, L. H., Harte, D., Sutherland, M., Parry, M. F., Smit, E., McAuliffe, G. N., Ussher, J. E., et al. (2021) · Pathology · doi:10.1016/j.pathol.2021.04.001 · Cited by 9 · see citing works

Applications of SARS-CoV-2 serological testing: impact of test performance, sample matrices, and patient characteristics

Fung, C. Y. J., Scott, M., Lerner‐Ellis, J. P., & Taher, J. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2254390 · Cited by 8 · see citing works

Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel

Dibernardo, A., Toledo, N., Robinson, A., Osiowy, C., Giles, E., Day, J., Lindsay, L. R., DREBOT, M. A., Booth, T. F., Pidduck, T., et al. (2022) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2021-0026 · Cited by 8 · see citing works

Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories

Plaga, A. R., Wei, R., Olson, E., Payto, D., Harrington, J. L., Nwe-Kissig, P. T., Strizzi, M., Zilka, S., Ko, J. S., & Colón-Franco, J. M. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab038 · Cited by 7 · see citing works

Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 Cohort

Wiwe, E. F., Carlsson, E. R., Rasmussen, C. L., Rasmussen, P., Ougaard, R., Hansen, S. I., Schiøler, T., Kristiansen, S. M., Hansen, Y. B. L., & Hillig, T. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab173 · Cited by 7 · see citing works

SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions

Mioch, D., Vanbrabant, L., Reimerink, J. H. J., Kuiper, S., Lodder, E. B., van den Bijllaardt, W., Kluytmans, J. A. J. W., Wissing, M. D., Augustijn, H., Bartels, M., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.025 · Cited by 7 · see citing works

Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population

Fernandes-Matano, L., Salas-Lais, Á. G., Grajales-Muñíz, C., Hernández‐Ávila, M., Garfias, Y., Rodríguez-Sepúlveda, M. C., Segura-Sánchez, C., Montes-Herrera, D., Mendoza-Sánchez, D., Ángeles-Martínez, J., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02376-22 · Cited by 7 · see citing works

Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours

Margalit, O., Shacham‐Shmueli, E., Itay, A., Berger, R., Halperin, S., Jurkowicz, M., Levin, E. G., Olmer, L., Regev‐Yochay, G., Lustig, Y., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.03.013 · Cited by 6 · see citing works

Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies

Lokida, D., Karyana, M., Kosasih, H., Mardian, Y., Sugiyono, R. I., Arlinda, D., Lukman, N., Salim, G., Butar-butar, D. P., Naysilla, A. M., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12614 · Cited by 6 · see citing works

SARS-CoV-2 antibody response dynamics and heterogeneous diagnostic performance of four serological tests and a neutralization test in symptomatic healthcare workers with non-severe COVID-19

Ong, D. S. Y., Keuren, F., van der Vliet, M., Klerk, B. M. B., & Koeleman, J. G. M. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104904 · Cited by 6 · see citing works

Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area

Igawa, G., Yamamoto, T. S., Baba, Y., Sinozuka, K., Yuri, M., Wakita, M., Misawa, S., Miida, T., Ai, T., & Tabe, Y. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08393 · Cited by 6 · see citing works

Highly Sensitive and Specific SARS-CoV-2 Serological Assay Using a Magnetic Modulation Biosensing System

Avivi-Mintz, S., Lustig, Y., Indenbaum, V., Schwartz, E., & Danielli, A. (2021) · Biosensors · doi:10.3390/bios12010007 · Cited by 6 · see citing works

Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination

Muhsen, K., Schwaber, M. J., Bishara, J., Kassem, E., Atamna, A., Na’amnih, W., Goren, S., Bialik, A., Mohsen, J., Zaaide, Y., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.689994 · Cited by 6 · see citing works

A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students

Lee, C. C., Segaloff, H. E., Cole, D., Rosenblum, H. G., Morgan, C. N., Somers, T. S., Desamu-Thorpe, R., Foster, M. A., Currie, D. W., Ruff, J. C., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07314-5 · Cited by 6 · see citing works

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data

Deichmann, J., Barda, N., Canetti, M., Peretz, Y., Weiss-Ottolenghi, Y., Lustig, Y., Regev‐Yochay, G., & Lipsitch, M. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013192 · Cited by 5 · see citing works

Association of Obesity with SARS-CoV-2 and Its Relationship with the Humoral Response Prior to Vaccination in the State of Mexico: A Cross-Sectional Study

Montes-Herrera, D., Muñoz‐Medina, J. E., Fernandes-Matano, L., Salas-Lais, Á. G., Hernández-Cueto, M. D. L. Á., Santacruz-Tinoco, C. E., Monroy-Muñoz, I. E., & Ángeles-Martínez, J. (2023) · Diagnostics · doi:10.3390/diagnostics13162630 · Cited by 5 · see citing works

Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model

Glémain, B., de Lamballerie, X. N., Zins, M., Severi, G., Touvier, M., Deleuze, J., SAPRIS-SERO study group, Carrat, F., Ancel, P., Charles, M.-A. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-60060-3 · Cited by 5 · see citing works

Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia

Kharroubi, G., Cherif, I., Ghawar, W., Dhaouadi, N., Yazidi, R., Châabane, S., Snoussi, M. A., Salem, S., Hamouda, W. B., Hamouda, S. B., et al. (2023) · Archives of Virology · doi:10.1007/s00705-022-05636-y · Cited by 5 · see citing works

Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand

Lerdsamran, H., Mungaomklang, A., Iamsirithaworn, S., Prasertsopon, J., Prasert, K., Intalapaporn, P., Siriyakorn, N., Wiriyarat, W., Thinpan, N., Sawadpongpan, S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06921-y · Cited by 5 · see citing works

Quantitative Analysis of Vertical Transmission of Maternal SARS-CoV-2 Antibodies to Neonates and Young Infants Following Immunization During Pregnancy

Golan, N., Ashkenazi, S., Davidovich, R., Levinsky, A., Chaim, A. B., Hamad, R. A., Raveh, O., Yitzhaki, S., & Livni, G. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac065 · Cited by 4 · see citing works

The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting

Hou, C., Williams, S., Soto, G. S. T., Boyle, V., Rainford, D., Vicino, S., Magee, M., Chung, Y., LaBaer, J., & Murugan, V. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003893 · Cited by 4 · see citing works

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection

Syre, H., Obreque, M. E. B., Dalen, I., Riis, Å. G., Berg, Å., Löhr, I. H., Sundal, J., Kleppe, L. K. S., Vadla, M. S., Lenning, O. B., et al. (2022) · Viruses · doi:10.3390/v14102196 · Cited by 4 · see citing works

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab

Hamaya, T., Hatakeyama, S., Yoneyama, T., Tobisawa, Y., Kodama, H., Fujita, T., Murakami, R., Mori, K., Okamoto, T., Yamamoto, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-42406-5 · Cited by 4 · see citing works

Unexpected False-Positive Rates in Pediatric SARS-CoV-2 Serology Using the EUROIMMUN Anti-SARS-CoV-2 ELISA IgG Assay

Geisler, D. L., Freeman, M. C., Rapsinski, G. J., & Wheeler, S. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab033 · Cited by 3 · see citing works

A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array

Fisher, M., Levy, H., Fatelevich, E., Afrimov, Y., Ben‐Shmuel, A., Rosenfeld, R., Noy-Porat, T., Glinert, I., Sittner, A., Biber, A., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00870-21 · Cited by 3 · see citing works

Sensitivity Affected by Disease Severity and Serum Sampling Time: a Performance Evaluation of Six SARS-CoV-2 Antibody Immunoassays

Şener, B., Kırbaş, E., Sancak, B., GÖZALAN, A., Evren, E., Karahan, Z. C., Zeytinoğlu, A., Dinç, B., Alp, A., Dizman, G. T., et al. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2021.636 · Cited by 3 · see citing works

Antibody response, associated symptoms and profile of patients presumably infected by SARS-CoV-2 with taste or smell disorders in the SAPRIS multicohort study

Ramillon, J., de Lamballerie, X. N., Robineau, O., Blanché, H., Severi, G., Touvier, M., Zins, M., Carrat, F., the SAPRIS-SERO study group, Ancel, P., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08162-7 · Cited by 3 · see citing works

A joint Bayesian hierarchical model for estimating SARS-CoV-2 genomic and subgenomic RNA viral dynamics and seroconversion

Dong, T. Q., & Brown, E. R. (2023) · Biostatistics · doi:10.1093/biostatistics/kxad016 · Cited by 2 · see citing works

Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe

Bartko, J., Zehetmayer, S., Weseslindtner, L., Stiasny, K., Schloegl, A., Forjan, E., Zwettler, E., Krauter, A., Keil, F., & Sédille-Mostafaie, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091909 · Cited by 2 · see citing works

Créches, écoles maternelles, la place de l'enfant handicapé

Titran, M. (2003) · Archives de Pédiatrie · doi:10.1016/s0929-693x(03)90386-1

Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories

Plaga, A. R., Wei, R., Olson, E., Payto, D., Harrington, J. L., Nwe-Kissig, P. T., Strizzi, M., Zilka, S., Ko, J. S., & Colón-Franco, J. M. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab038 · Cited by 7 · see citing works

Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 Cohort

Wiwe, E. F., Carlsson, E. R., Rasmussen, C. L., Rasmussen, P., Ougaard, R., Hansen, S. I., Schiøler, T., Kristiansen, S. M., Hansen, Y. B. L., & Hillig, T. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab173 · Cited by 7 · see citing works

Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study

Baron, R. C., Risch, L., Weber, M. C., Thiel, S. L., Grossmann, K., Wohlwend, N., Lung, T., Hillmann, D., Ritzler, M., Bigler, S., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0978 · Cited by 53 · see citing works

Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19

Suhandynata, R. T., Hoffman, M. A., Kelner, M. J., McLawhon, R. W., Reed, S. L., & Fitzgerald, R. L. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa139 · Cited by 30 · see citing works